Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Inflammatory Bowel Diseases

  Free Subscription


08.06.2026

2 Aliment Pharmacol Ther
2 Clin Gastroenterol Hepatol
2 Dig Dis Sci
1 Dis Colon Rectum
2 Gastroenterology
6 Inflamm Bowel Dis
1 J Clin Gastroenterol
2 J Crohns Colitis


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. DUBE LR, Sorin M, Allez M, Afif W, et al
    The Association of Faecal Calprotectin Measurements With Endo-Histological Remission in Ulcerative Colitis: A Pooled Analysis.
    Aliment Pharmacol Ther. 2026 Jun 2. doi: 10.1111/apt.70735.
    PubMed         Abstract available

  2. GOYAL MK, Bishu S
    Editorial: Upadacitinib in Perianal Crohn's Disease.
    Aliment Pharmacol Ther. 2026 Jun 2. doi: 10.1111/apt.70759.
    PubMed        


    Clin Gastroenterol Hepatol

  3. GOLD S, Day AS, Wine E, Lindsay JO, et al
    Defining Research Priorities in Nutrition and Inflammatory Bowel Disease: Insights from the Nutrition and IBD Research Group.
    Clin Gastroenterol Hepatol. 2026 Jun 2:S1542-3565(26)00401.
    PubMed         Abstract available

  4. TOTH E, Koulaouzidis A
    Re: Palmela et al. Use of Intestinal Ultrasound in a Tight Monitoring Approach in Crohn's Disease: A Multicentre Prospective Study.
    Clin Gastroenterol Hepatol. 2026 Jun 3:S1542-3565(26)00407.
    PubMed        


    Dig Dis Sci

  5. BARKAN R, Goren I, Fischman M, Avni-Biron I, et al
    Randomized Trial of Intensive Nurse-Led Follow?Up Versus Standard Care in Inflammatory Bowel Disease.
    Dig Dis Sci. 2026 Jun 2. doi: 10.1007/s10620-026-10015.
    PubMed         Abstract available

  6. NATT N, Choi D, Shafrir A, Dalal SR, et al
    Combining Guselkumab with Upadacitinib Is Safe and Effective in the Treatment of Medically Complex Inflammatory Bowel Disease.
    Dig Dis Sci. 2026 Jun 4. doi: 10.1007/s10620-026-09995.
    PubMed         Abstract available


    Dis Colon Rectum

  7. LUO Y, Yue CC
    Comment on "Recurrence After Ileocolic Resection for Crohn's Disease: Further Unraveling the Search for Risk Factors".
    Dis Colon Rectum. 2026 Jun 5. doi: 10.1097/DCR.0000000000004316.
    PubMed        


    Gastroenterology

  8. GHIBOUB M, de Jonge WJ, van Limbergen JE
    Dietary therapy potential to recapitulate Faecalibacterium prausnitzii-driven OXPHOS-dependent immunoregulation in pediatric Crohn's disease.
    Gastroenterology. 2026 May 30:S0016-5085(26)06944.
    PubMed        

  9. ZHAO Z, Zhao X, Zhang G
    Bridging Genetics and Bedside Decisions in Inflammatory Bowel Disease: Utility Metrics for Susceptibility Polygenic Scores.
    Gastroenterology. 2026 May 19:S0016-5085(26)06876.
    PubMed        


    Inflamm Bowel Dis

  10. KIM ES, Kim DH, Kim SJ, Park SH, et al
    Distinct predictive factors for acute severe ulcerative colitis in East Asian and Western populations.
    Inflamm Bowel Dis. 2026 Jun 5:izag098. doi: 10.1093.
    PubMed         Abstract available

  11. BRAND EC, Vandoren R, Lutter L, Van Deuren VML, et al
    Clonal overlap and convergent clustering of T cell receptor signatures in Crohn's disease in monozygotic twins.
    Inflamm Bowel Dis. 2026 Jun 5:izag078. doi: 10.1093.
    PubMed         Abstract available

  12. ORLIN I, Younis B, Gasparetto M, Yerushalmy-Feler A, et al
    Clinical and radiological outcomes of ustekinumab in pediatric perianal Crohn's disease: a multicenter retrospective study from the Pediatric IBD Porto Group of ESPGHAN.
    Inflamm Bowel Dis. 2026 Jun 2:izag091. doi: 10.1093.
    PubMed         Abstract available

  13. ST-PIERRE J, Delisle M, Miyatani Y, Falloon K, et al
    Ultrasound criteria for transmural healing and response in Crohn's disease: a systematic review of definitions and thresholds.
    Inflamm Bowel Dis. 2026 Jun 1:izag052. doi: 10.1093.
    PubMed         Abstract available

  14. NORGARD BM, Zeiss KE, Dalal RS, Lund K, et al
    Chronic opioid use and the risk of infections and death in patients with inflammatory bowel disease: a nationwide cohort study based on real-world data.
    Inflamm Bowel Dis. 2026 May 31:izag085. doi: 10.1093.
    PubMed         Abstract available

  15. YUAN Y, Jairath V, Hanzel J, Hupe M, et al
    Biologics and small molecules for perianal Crohn's disease: a systematic review and meta-analyses of randomized placebo-controlled trials.
    Inflamm Bowel Dis. 2026 May 30:izag099. doi: 10.1093.
    PubMed         Abstract available


    J Clin Gastroenterol

  16. DAI C, Huang YH
    Impact of Clostridioides difficile Infection on Clinical Outcomes in Hospitalized Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2026 Jun 5. doi: 10.1097/MCG.0000000000002408.
    PubMed        


    J Crohns Colitis


  17. Correction to: Placebo rates in randomized clinical trials of ulcerative colitis: an individual patient data meta-analysis.
    J Crohns Colitis. 2026;20:jjag070.
    PubMed        

  18. WEHKAMP L, Harris DMM, Kim NM, Alsaadi AI, et al
    A metabolic constraint in de novo NAD+ synthesis drives mucosal inflammation in IBD.
    J Crohns Colitis. 2026;20:jjag043.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum